MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-25-2026
TELA Bio Operating Expenses 2011-2026 | TELA
Annual Operating Expenses TELA Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88.1 M | 88.2 M | 84.2 M | 66.1 M | 48.3 M | 36.5 M | 28.4 M | 22.9 M | 19.5 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 88.2 M | 19.5 M | 53.6 M |
Quarterly Operating Expenses TELA Bio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.5 M | 23.2 M | 23 M | - | 22.2 M | 22.6 M | 23.7 M | - | 20.6 M | 20.6 M | 19.2 M | - | 16.8 M | 16.8 M | 14.8 M | - | 11.8 M | 12.4 M | 10.7 M | - | 10.2 M | 7.25 M | 8.7 M | - | 6.46 M | 6.21 M | 6.98 M | - | 3.89 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 23.7 M | 3.89 M | 15 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 13.14 | 0.23 % | $ 1.78 B |  USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.69 | 2.99 % | $ 383 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 26.13 | 1.04 % | $ 221 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.36 | 1.05 % | $ 126 M |  France |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.21 | 0.22 % | $ 317 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.09 | 2.21 % | $ 1.27 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 56.54 | 0.76 % | $ 1.66 B | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.63 | 2.87 % | $ 39.2 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 60.35 | 0.42 % | $ 3.29 B |  Britain |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.08 | 4.37 % | $ 18.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.26 | 1.29 % | $ 358 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.9 | 2.51 % | $ 1.04 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 90.84 | 0.7 % | $ 12.3 B | USA |
 |
NanoVibronix
NAOV
|
23 M | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 37.36 | 1.77 % | $ 1.16 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 87.13 | -1.61 % | $ 3.03 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 83.61 | 0.1 % | $ 48.9 B | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.08 | 0.2 % | $ 5.77 M | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 304.09 | -3.48 % | $ 116 B | USA |
 |
TransMedics Group
TMDX
|
254 M | $ 100.78 | -0.01 % | $ 3.43 B | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.21 | -0.38 % | $ 62.3 M | USA |
 |
Tandem Diabetes Care
TNDM
|
159 M | $ 19.81 | 1.46 % | $ 1.35 B | USA |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.33 | 3.91 % | $ 54.1 M | USA |
 |
MiMedx Group
MDXG
|
277 M | $ 3.58 | 6.55 % | $ 529 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.87 | 1.21 % | $ 36.4 M | USA |